novo nordisk semaglutide alzheimer trial reports 2 failures for GLP-1 in Alzheimer's disease Novo Nordisk's semaglutide misses in

Jody Dushay, an assistant professor of medicine at Harvard Medical School and an attending physician in endocrinology at Beth Israel Deaconess Medical Center, previously told CNN

The protein helps keep you full, while the greens add fiber and important nutrients

As per the April 2023 NLM study evaluating a total of 21 clinical trials comprising 1,204 adults diagnosed with gentle cognitive impairment, incorporated supplements having 1.5 to 3.0 g/day acetyl-L-carnitine or placebo for about 3 to 12 months that resulted in greater improvements in participants who used supplements when compared to placebo participants

Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia